Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer

E Chirshev, KC Oberg, YJ Ioffe… - Clinical and translational …, 2019 - Springer
Abnormal regulation and expression of microRNAs (miRNAs) has been documented in
various diseases including cancer. The miRNA let-7 (MIRLET7) family controls …

MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction

FJ Nassar, R Nasr, R Talhouk - Pharmacology & therapeutics, 2017 - Elsevier
Breast cancer is a major health problem that affects one in eight women worldwide. As such,
detecting breast cancer at an early stage anticipates better disease outcome and prolonged …

The network of non-coding RNAs in cancer drug resistance

F Corrà, C Agnoletto, L Minotti, F Baldassari… - Frontiers in …, 2018 - frontiersin.org
Non-coding RNAs (ncRNAs) have been implicated in most cellular functions. The disruption
of their function through somatic mutations, genomic imprinting, transcriptional and post …

Epigenetics of aging and Alzheimer's disease: Implications for pharmacogenomics and drug response

R Cacabelos, C Torrellas - International journal of molecular sciences, 2015 - mdpi.com
Epigenetic variability (DNA methylation/demethylation, histone modifications, microRNA
regulation) is common in physiological and pathological conditions. Epigenetic alterations …

Influence of microRNAs and long non-coding RNAs in cancer chemoresistance

D Ayers, J Vandesompele - Genes, 2017 - mdpi.com
Innate and acquired chemoresistance exhibited by most tumours exposed to conventional
chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such …

Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer

J Wu, S Zhang, J Shan, Z Hu, X Liu, L Chen, X Ren… - Cancer letters, 2016 - Elsevier
High mobility group AT-hook 2 (HMGA2) is involved in a wide spectrum of biological
processes and is upregulated in several tumors. Here, we collected 273 breast cancer (BC) …

miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis

Z Zhang, H Zhang, J Yu, L Xu, X Pang, Q Xiang… - Breast cancer research …, 2022 - Springer
Purpose Accumulating evidence has shown that microRNAs (miRNAs) are promising
biomarkers of neoadjuvant chemotherapy (NAC) response in breast cancer (BC). However …

Identification of specific miRNA signature in paired sera and tissue samples of Indian women with triple negative breast cancer

S Thakur, RK Grover, S Gupta, AK Yadav, BC Das - PloS one, 2016 - journals.plos.org
Of several subtypes of breast cancer, triple negative breast cancer (TNBC) is a highly
aggressive tumor that lacks expression of hormone receptors for estrogen, progesterone …

Clinical theragnostic relationship between drug-resistance specific miRNA expressions, chemotherapeutic resistance, and sensitivity in breast cancer: a systematic …

R Jayaraj, MR Madhav, SG Nayagam, A Kar… - Cells, 2019 - mdpi.com
Awareness of breast cancer has been increasing due to early detection, but the advanced
disease has limited treatment options. There has been growing evidence on the role of …

Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?

A Ritter, M Hirschfeld, K Berner… - International …, 2020 - spandidos-publications.com
Due to the positive association between neoadjuvant chemotherapy (NACT) and the
promising early response rates of patients with triple negative breast cancer (TNBC) …